KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Asset Utilization Ratio (2016 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Asset Utilization Ratio for 11 consecutive years, with 0.01 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio changed N/A to 0.01 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01, a N/A change, with the full-year FY2025 number at 0.01, changed N/A from a year prior.
  • Asset Utilization Ratio was 0.01 for Q4 2025 at Xenon Pharmaceuticals, up from 0.01 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.12 in Q1 2021 to a low of 0.0 in Q2 2023.
  • A 4-year average of 0.03 and a median of 0.01 in 2022 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: soared 139.32% in 2021, then crashed 99.27% in 2023.
  • Xenon Pharmaceuticals' Asset Utilization Ratio stood at 0.04 in 2021, then tumbled by 65.19% to 0.01 in 2022, then tumbled by 98.48% to 0.0 in 2023, then skyrocketed by 6331.62% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for XENE's Asset Utilization Ratio are 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025).